3-Indoleacrylic acid structure 
             | 
        Common Name | 3-Indoleacrylic acid | ||
|---|---|---|---|---|
| CAS Number | 29953-71-7 | Molecular Weight | 187.195 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 432.8±20.0 °C at 760 mmHg | |
| Molecular Formula | C11H9NO2 | Melting Point | 185 °C (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | 215.6±21.8 °C | |
| Symbol | 
             
            
            GHS07  | 
        Signal Word | Warning | |
| Name | trans-3-Indoleacrylic acid | 
|---|---|
| Synonym | More Synonyms | 
| Density | 1.4±0.1 g/cm3 | 
|---|---|
| Boiling Point | 432.8±20.0 °C at 760 mmHg | 
| Melting Point | 185 °C (dec.)(lit.) | 
| Molecular Formula | C11H9NO2 | 
| Molecular Weight | 187.195 | 
| Flash Point | 215.6±21.8 °C | 
| Exact Mass | 187.063324 | 
| PSA | 53.09000 | 
| LogP | 2.34 | 
| Vapour Pressure | 0.0±1.1 mmHg at 25°C | 
| Index of Refraction | 1.750 | 
| Water Solubility | freely soluble | 
| Symbol | 
                                    
                                     
                                    
                                    GHS07  | 
                            
|---|---|
| Signal Word | Warning | 
| Hazard Statements | H315-H319-H335 | 
| Precautionary Statements | P261-P305 + P351 + P338 | 
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves | 
| Hazard Codes | Xi:Irritant; | 
| Risk Phrases | R36/37/38 | 
| Safety Phrases | S26-S36-S37/39 | 
| RIDADR | NONH for all modes of transport | 
| WGK Germany | 3 | 
| RTECS | NL3680000 | 
| 
                                    
                                    Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
                                    
                                    
                                     J. Med. Chem. 54 , 5320, (2011) Tryptophan catabolism mediated by indoleamine 2,3-dioxygenase (IDO) is an important mechanism of peripheral immune tolerance contributing to tumoral immune resistance. IDO inhibition is thus an active...  | 
                                |
| 
                                    
                                    Structural insight into the inhibition of human kynurenine aminotransferase I/glutamine transaminase K.
                                    
                                    
                                     J. Med. Chem. 52 , 2786-93, (2009) Human kynurenine aminotransferase I (hKAT I) catalyzes the formation of kynurenic acid, a neuroactive compound. Here, we report three high-resolution crystal structures (1.50-1.55 A) of hKAT I that ar...  | 
                                |
| 
                                    
                                    Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3.
                                    
                                    
                                     Molecules 20 , 7059-96, (2015) Multivalent protein-carbohydrate interactions that are mediated by sugar-binding proteins, i.e., lectins, have been implicated in a myriad of intercellular recognition processes associated with tumor ...  | 
                                
| 3-Indoleacrylic acid | 
| (E)-3-(indol-3-yl)acrylic acid | 
| 2-Propenoic acid, 3-(1H-indol-3-yl)-, (2E)- | 
| INDOLE ACRYLIC ACID | 
| INDOLE-3-ACRYLIC ACID | 
| 2-Propenoic acid, 3- (1H-indol-3-yl)- | 
| Indole-3-butyic acid | 
| 3-(3-INDOLYL)ACRYLIC ACID | 
| (2E)-3-(1H-Indol-3-yl)acrylic acid | 
| trans-Indole-3-acrylic acid | 
| (2E)-3-(1H-indol-3-yl)prop-2-enoic acid | 
| Indole-3-crylic acid | 
| Trans-3-Indoleacrylicn | 
| EINECS 214-872-7 | 
| MFCD00005633 | 
| RARECHEM BK HD 0025 |